Skip to content

NeuroCatch Platform 2.0

by NeuroCatch Inc 4 variants

NeuroCatch Platform 2.0 (NCP2) is a Class II device made by NeuroCatch Inc, listed in FDA GUDID since 25 Aug 2022 (UDI-DI G134NCP21), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberG134NCP21 UDI-DI Date25 Aug 2022ListedStatusListed GUDID: in commercial distribution

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
NeuroCatch Platform
Generic name
Electroencephalograph
Model / Ref / Catalog
2.0, NCP2
Description
NeuroCatch Platform system REF: NCP2
Primary DI / UDI-DI
G134NCP21
FDA product code
PTY
GMDN term
Electroencephalograph
Device class
Class II
Regulation number
882.1470
GUDID distribution status
In Commercial Distribution

Related devices

Category: Electroencephalograph

Similar devices in this category

Other devices filed under Electroencephalograph.

Other devices from NeuroCatch Inc

See all devices from NeuroCatch Inc →

Properties

  • Premarket exempt
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)